Organisation paid for research Program year 2024 Source: CMS Open Payments

WCCT Global

Neither a doctor nor a teaching hospital

Research payments

$3,789,231

7 payments

Through program year 2024, WCCT Global is reported as receiving $3,789,231 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$1,385,663	3
2023	Research	$2,400,653	2
2020	Research	$2,915	2

Breakdown

Who paid Research payments · program years 2020–2024

E.R. Squibb & Sons, L.L.C. $3,786,316 5 payments
OPKO Pharmaceuticals, LLC $2,915 2 payments

Studies the money was for Research payments · program years 2020–2024

Single Ascending Dose (Japan) $1,393,879 1 payment
CN008-0016 (BMS-986446, Prothena PRX005) Anti-Tau Alzheimers Disease $1,214,874 1 payment
DDI (OC dose 2 -3 weeks) - A Phase 1, Single-center, Open-label, Single-sequence Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 With Oral Contraceptives in Healthy Female Participants $1,006,774 1 payment
Evaluation of the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics ofBMS-986325 in Healthy Japanese Participants $155,812 1 payment
A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants $14,977 1 payment
Repeated-dose Safety, Efficacy, PK and PD of CTAP101, IR Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With SHPT, CKD 3-4 and VDI $2,915 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.